LYZA
- Product NDC
- 50102-100
- 11-digit product format
- 501020100
- Labeler code
- 50102
- Product ID
- 50102-100_8382cbc8-a13d-4c17-a076-d878690cb873
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- norethindrone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Afaxys Pharma LLC
- Application
- ANDA200980
- Marketing category
- ANDA
- Marketing start
- 2013-06-24
- Marketing end
- 0000-00-00
- Substance
- NORETHINDRONE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50102-100 | LYZA (NORETHINDRONE) TABLET [AFAXYS PHARMA LLC] | 13 | Legacy NDC, 5 package rows | 20210128_fe2cb3eb-dcd0-470c-8cf0-78fda554b1f7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50102-100-00 | 50102010000 | 28 in 1 BLISTER PACK | | | | | | Historical |
| 50102-100-01 | 50102010001 | 1 in 1 PACKAGE | | | | | | Historical |
| 50102-100-03 | 50102010003 | 3 PACKAGE in 1 CARTON (50102-100-03) > 1 BLISTER PACK in 1 PACKAGE (50102-100-10) > 28 TABLET in 1 BLISTER PACK (50102-100-00) | 3 package | 2017-07-01 | 0000-00-00 | No | No | Current |
| 50102-100-10 | 50102010010 | 1 in 1 PACKAGE | | | | | | Historical |
| 50102-100-48 | 50102010048 | 48 PACKAGE in 1 CASE (50102-100-48) > 1 BLISTER PACK in 1 PACKAGE (50102-100-01) > 28 TABLET in 1 BLISTER PACK (50102-100-00) | 48 package | 2013-07-18 | 0000-00-00 | No | No | Current |